![]() |
|
|
Vol. 27, Issue 11, 1267-1273, November 1999
Dow Corning Corporation (S.V., K.P.P., S.N.), Midland, Michigan;
and SmithKline Beecham (K.L.S.), King of Prussia, Pennsylvania
Octamethylcyclotetrasiloxane (D4) is an industrial
chemical of significant commercial importance. In this study, its major urinary metabolites were identified. The urine samples described here
were collected from male and female Fischer rats (F-344) administered
[14C]D4 i.v. The metabolite profile was
obtained using an HPLC system equipped with a radioisotope
detector. HPLC analysis was performed on a C18 column, using an
acetonitrile/water mobile phase. The HPLC radiochromatogram revealed
two major and at least five minor metabolites. The two major
metabolites, constituting 75 to 85% of the total radioactivity, were
identified as dimethylsilanediol [Me2Si(OH)2]
and methylsilanetriol [MeSi(OH)3]. Formation of
MeSi(OH)3 clearly established demethylation at the
silicon-methyl bonds of D4. No parent D4 was
present in urine. The minor metabolites identified were
tetramethyldisiloxane-1,3-diol
[Me2Si(OH)-O-Si(OH)Me2], hexamethyltrisiloxane-1,5-diol
[Me2Si(OH)-OSiMe2-OSi(OH)Me2], trimethyldisiloxane-1,3,3-triol
[MeSi(OH)2-O-Si(OH)Me2],
dimethyldisiloxane-1,1,3,3-tetrol [MeSi(OH)2-O-Si(OH)2Me], and
dimethyldisiloxane-1,1,1,3,3-pentol [Si(OH)3-O-Si(OH)2Me]. The structural
assignments were based on gas chromatography-mass spectrometry
analysis of the tetrahydrofuran metabolite extracts, which were
derivatized using bis(trimethylsiloxy)triflouroacetamide, a
trimethylsilylating agent. The structures were confirmed by synthesizing 14C-labeled standards and comparing their HPLC
radiochromatograms with the corresponding components in the rat urine.
GC-MS spectral comparisons of the trimethylsilylated derivatized
standards and urinary components also were made to further confirm
their identities. Finally, several of the urinary metabolites were
fractionated using HPLC, and GC-MS comparisons were again made for
positive structural identification. The pathways for metabolite
formation are not yet understood, but a mechanistic hypothesis has been proposed to account for the various metabolites observed thus far.
This article has been cited by other articles:
![]() |
M. B. Reddy, I. D. Dobrev, D. A. McNett, J. M. Tobin, M. J. Utell, P. E. Morrow, J. Y. Domoradzki, K. P. Plotzke, and M. E. Andersen Inhalation Dosimetry Modeling with Decamethylcyclopentasiloxane in Rats and Humans Toxicol. Sci., October 1, 2008; 105(2): 275 - 285. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Fisher PBPK Modeling Advances Understanding of D4 Pharmacokinetics Toxicol. Sci., March 1, 2003; 72(1): 1 - 2. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. B. Reddy, M. E. Andersen, P. E. Morrow, I. D. Dobrev, S. Varaprath, K. P. Plotzke, and M. J. Utell Physiological Modeling of Inhalation Kinetics of Octamethylcyclotetrasiloxane in Humans during Rest and Exercise Toxicol. Sci., March 1, 2003; 72(1): 3 - 18. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Varaprath, J. M. McMahon, and K. P. Plotzke Metabolites of Hexamethyldisiloxane and Decamethylcyclopentasiloxane in Fischer 344 Rat Urine---A Comparison of a Linear and a Cyclic Siloxane Drug Metab. Dispos., February 1, 2003; 31(2): 206 - 214. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Andersen, R. Sarangapani, R. H. Reitz, R. H. Gallavan, I. D. Dobrev, and K. P. Plotzke Physiological Modeling Reveals Novel Pharmacokinetic Behavior for Inhaled Octamethylcyclotetrasiloxane in Rats Toxicol. Sci., April 1, 2001; 60(2): 214 - 231. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. P. Plotzke, S. D. Crofoot, E. S. Ferdinandi, J. G. Beattie, R. H. Reitz, D. A. McNett, and R. G. Meeks Disposition of Radioactivity in Fischer 344 Rats after Single and Multiple Inhalation Exposure to [14C]Octamethylcyclotetrasiloxane ([14C]D4) Drug Metab. Dispos., February 1, 2000; 28(2): 192 - 204. [Abstract] [Full Text] |
||||